Table 2.
Overview on the intensive care treatment and other outcome variables
| Control | Intervention | Relative mean difference with 95% CI | Relative risk with 95% CI |
p value | |
|---|---|---|---|---|---|
| Severe adverse event (SAE) | 0 (0%) | 0 (0%) | |||
| ICU-Treatment | |||||
| Renal replacement therapy | 9 (12.5%) | 7 (10.1%) | |||
| Mechanical ventilation | 64 (88.9%) | 60 (87%) | |||
| Extracorporeal life support | 4 (6.1%) | 3 (4.6%) | |||
| Limitation of Life-sustaining therapy | |||||
| Therapy withdrawn | 10 (15.2%) | 14 (21.9%) | |||
| Therapy withheld | 12 (18.2%) | 10 (15.6%) | |||
| Any limitation of LST | 27 (38%) | 29 (42%) | |||
| Day of any limitation of LST | 2 (± 5) | 2 (± 5) | |||
| Outcome | |||||
| Length of stay ICU [days] | 5.5 (± 13) | 5.5 (± 11.75) | −1.44 (-9.36 to 5.47) | 0.745 | |
| Length of stay hospital-[days] | 10.5 (± 15.75) | 12 (± 13.75) | −3.33 (-11.08 to 4.43) | 0.634 | |
| 30-days-Mortality | 25 (34.7%) | 32 (47.1%) | RR 1.39 (0.91–1.97) | 0.138 |
ICU Intensive Care Unit, LST Life-sustaining therapy, *Mean + standard deviation, †Median + interquartil range. (for missing values see supplemental Table 4)